ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
yelrom
|
549 |
179K |
31 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
179K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
9.8K |
2.9M |
22 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
9.8K
|
2.9M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
yelrom
|
1.3K |
554K |
40 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
554K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
yelrom
|
1.3K |
554K |
35 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
554K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
yelrom
|
3.4K |
1.2M |
38 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
38
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
9.8K |
2.9M |
33 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
9.8K
|
2.9M
|
33
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
yelrom
|
3.4K |
1.2M |
37 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
yelrom
|
1.0K |
391K |
31 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
yelrom
|
1.0K |
391K |
31 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
18 |
05/03/23 |
05/03/23 |
ASX - By Stock
|
905
|
286K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
9.8K |
2.9M |
42 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
9.8K
|
2.9M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
9.8K |
2.9M |
16 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
9.8K
|
2.9M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
9.8K |
2.9M |
42 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
9.8K
|
2.9M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
9.8K |
2.9M |
26 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
12 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
17K
|
6.7M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
26 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
17K
|
6.7M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
19 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
905
|
286K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q3 Financial Results and Operational Highlights
|
|
yelrom
|
177 |
60K |
39 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
177
|
60K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
yelrom
|
317 |
73K |
41 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
317
|
73K
|
41
|
|
ASX - By Stock
|
MSB |
Re:
rurenga
|
|
yelrom
|
62 |
22K |
42 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
62
|
22K
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
14 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
17K
|
6.7M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
MSB - Maximum Market Size
|
|
yelrom
|
68 |
22K |
43 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
68
|
22K
|
43
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q2 Financial Results Webcast
|
|
yelrom
|
23 |
9.6K |
16 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
23
|
9.6K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Biotech Showcase 2022 Presentation
|
|
yelrom
|
39 |
14K |
25 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
39
|
14K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ulcerative Colitis & Crohns Results Presented at ECCO
|
|
yelrom
|
202 |
85K |
33 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
202
|
85K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Is Rome burning
|
|
yelrom
|
90 |
25K |
24 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
90
|
25K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
yelrom
|
1.0K |
330K |
32 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
1.0K
|
330K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
yelrom
|
1.0K |
330K |
33 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
1.0K
|
330K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
yelrom
|
880 |
214K |
4 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
880
|
214K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
yelrom
|
880 |
214K |
33 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
880
|
214K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
yelrom
|
1.0K |
330K |
28 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
1.0K
|
330K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Capital Raising - Coming Soon?
|
|
yelrom
|
46 |
10K |
10 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
46
|
10K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
20 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
17K
|
6.7M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
2022.. Baba...Bababa..BOOM
|
|
yelrom
|
3 |
1.7K |
35 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
3
|
1.7K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
yelrom
|
267 |
64K |
24 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
yelrom
|
267 |
64K |
9 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
yelrom
|
267 |
64K |
40 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
yelrom
|
267 |
64K |
0 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
yelrom
|
373 |
88K |
27 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
373
|
88K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Prospectus for Warrants Related to Oaktree Debt Refinance
|
|
yelrom
|
12 |
6.2K |
42 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
12
|
6.2K
|
42
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
yelrom
|
1.5K |
505K |
51 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
1.5K
|
505K
|
51
|
|
ASX - By Stock
|
MSB |
Re:
Merry X-mass, Happy new year & Standby for Blast off or annihilation!
|
|
yelrom
|
35 |
13K |
11 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
35
|
13K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Merry X-mass, Happy new year & Standby for Blast off or annihilation!
|
|
yelrom
|
35 |
13K |
56 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
35
|
13K
|
56
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
33 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
422
|
145K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
The great Msb short unwind
|
|
yelrom
|
140 |
38K |
30 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
140
|
38K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
35 |
18/12/21 |
18/12/21 |
ASX - By Stock
|
905
|
286K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
yelrom
|
408 |
124K |
24 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
408
|
124K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
yelrom
|
850 |
251K |
27 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
850
|
251K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Novartis walked due to "sub par data".
|
|
yelrom
|
143 |
41K |
37 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
143
|
41K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
yelrom
|
850 |
251K |
16 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
850
|
251K
|
16
|
|